Dr. Clair Francomano

Dr. Clair Francomano, a prominent expert in connective tissue disorders and Chair of the Ehlers-Danlos Society's advisory board, dives into the nuances of hypermobile Ehlers-Danlos Syndrome (hEDS) versus hypermobility spectrum disorders (HSD). She highlights the complexities surrounding genetic testing, including key warning signs for clinicians and new research on biomarkers that could transform diagnosis. Francomano also discusses the interconnections between hEDS and conditions like mast cell activation syndrome (MCAS) and postural orthostatic tachycardia syndrome (POTS), offering valuable insights for patients.